Skip to content

Unilife Medical Solutions

Investor Relations


Unilife is a U.S. based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for our products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. All of our syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. We are ISO 13485 certified and have FDA-registered medical device manufacturing facilities in Pennsylvania.

Read More »

Recent Releases

Sep 1, 2010
Unilife Corporation Secures FDA 510k Clearance for the Unitract(TM) 1mL Tuberculin Syringe

Aug 30, 2010
Unilife Corporation Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2010

View all releases »

Events & Presentations

Sep 12, 2010
Rodman & Renshaw Annual Healthcare Global Investment Conference

Sep 20, 2010
UBS Global Life Sciences Conference

View all events & presentations »

Financial Information
Financial Summary
SEC Filings
Annual Reports
Quarterly Results
Key Ratios
Stock Information
Stock Performance
Historic Stock Lookup
Investment Calculator
Analyst Coverage
ASX Stock Data
News and Events
Press Releases
Events
Presentations
Corporate Governance
Introduction
Management
Board of Directors
Committee Composition
Policies and Guidelines
Ethics Hotline
Contact the Board
Investor Facts
Trading on Unilife FAQ
Tax Ruling
Contact Us
Contact Us


NASDAQ:UNIS
Date  Sep 2, 2010
Time  4:00 PM ET
Last Price  $5.09
Change  - 0.15 (2.863%)
Quotes delayed at least 20 minutes.
Information provided by eSignal.